통풍의 새로운 진단 분류 기준과 치료 지침

Gout is a chronic systemic metabolic disease characterized by recurrent attacks of inflammatory arthritis resulting from the precipitation of monosodium urate crystals, which has various clinical and pathological manifestations. The disease is associated with multiple comorbidities, an impaired qual...

Full description

Saved in:
Bibliographic Details
Published inThe Korean journal of medicine Vol. 93; no. 4; pp. 344 - 350
Main Authors 송정수, Jung Soo Song
Format Journal Article
LanguageKorean
Published 대한내과학회 01.08.2018
Subjects
Online AccessGet full text
ISSN1738-9364
2289-0769

Cover

More Information
Summary:Gout is a chronic systemic metabolic disease characterized by recurrent attacks of inflammatory arthritis resulting from the precipitation of monosodium urate crystals, which has various clinical and pathological manifestations. The disease is associated with multiple comorbidities, an impaired quality of life, and a heavy economic burden. The incidence and prevalence of gout is increasing in many developed and developing countries, as in Korea. Gout is diagnosed by confirming monosodium urate crystals in the synovial fluid or affected tissue. If crystal documentation is unavailable, new gout classification criteria presented by the American College of Rheumatology and European League Against Rheumatism (ACR/EULAR) in 2015 can be applied. There are many guidelines for managing gout published in the United States, Japan, and Europe. However, there are no guidelines for the tailored management of gout for Korean patients. This review describes a new classification for the diagnosis of gout and management guidelines. (Korean J Med 2018;93:344-350)
Bibliography:The Korean Association Of Internal Medicine
ISSN:1738-9364
2289-0769